No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
APVO Aptevo Therapeutics
- 0.680
- -0.003-0.38%
Close Apr 25 16:00 ET
- 0.720
- +0.040+5.81%
Post 18:23 ET
2.44MMarket Cap-10P/E (TTM)
0.708High0.670Low367.85KVolume0.680Open0.683Pre Close249.49KTurnover10.25%Turnover RatioLossP/E (Static)3.59MShares84.96852wk High0.20P/B2.44MFloat Cap0.67052wk Low--Dividend TTM3.59MShs Float3911.600Historical High--Div YieldTTM5.51%Amplitude0.670Historical Low0.678Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
US Equity Markets Close Mixed After March Producer Price Inflation Data
US equity markets closed mixed Thursday following the wholesale producer price inflation data for March. * The US producer price index increased 2.1% year-over-year in March, accelerating from 1.6% in
Why Aptevo Therapeutics Stock Is Cratering
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower Thursday after the company priced its $4.6 million public offering.The Details:Aptevo announced the pricing of a public offering of 3,40
Top Midday Decliners
Aptevo Therapeutics (APVO) said it priced a public offering of 3.4 million shares and warrants to purchase up to 6.8 million shares at $1.35 a share and associated common warrant, targeting gross proc
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9
NKTR, VERU and EGIO Among Mid-day Movers
Dow Dips 100 Points; CarMax Earnings Miss Views
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. The Dow traded down 0.35% to 38,328.18 while the NASDAQ rose 0.50% to 16,251.71. The S&
Comments
$Aptevo Therapeutics(APVO.US$ .. still drop..no chance to raise next to few months
Wow just brutal! But a buy opportunity possibly!
$Aptevo Therapeutics(APVO.US$ Yes this is pretty heavily shorted! But DAMN! Talk about a offering that has done some serious damage! Sheesh! Its gotta be the addition of the terrible CPI numbers that caused maybe like zero buy pressure at all that added to the massive drop! I mean as far as offerings/dilution goes. This was just a baby offering! Well i guess if you’re already in and at a pretty hi price? If you really like it? Its a place to avera...
3
3
$Aptevo Therapeutics(APVO.US$
NEWS
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
NEWS
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4
News
$Aptevo Therapeutics(APVO.US$ Aptevo Therapeutics Announces Advancements In Clinical Programs And One Preclinical Program
Benzinga· 1 min ago
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the potential for greater clinical benefit in the ALG.APV-527 clinical trial
Cohort 5 dosing imminent, trial more than 50% enrolled
APVO436 Phase 1b/2 dose ...
Benzinga· 1 min ago
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the potential for greater clinical benefit in the ALG.APV-527 clinical trial
Cohort 5 dosing imminent, trial more than 50% enrolled
APVO436 Phase 1b/2 dose ...
2
4
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg